[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Can-Am HIFU Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":58},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":24,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100454714","canadian-cohort-of-convective-thermal-therapy-using-rezm-system-in-benign-prostatic-hyperplasia-bph-100454714",false,"NCT05201131","Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Male subjects of ≥ 18 years of age.\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH).\n* Candidate for Rezūm therapy as per clinical decision of Investigator.\n* Willing and able to accurately complete the required questionnaires.\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":18,"type":19},50,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.",[23],"Urologic Diseases",[25],"benigh prostate hypertrophy","RECRUITING","2022-01-07",{"date":29,"type":30},"2022-01-21","ACTUAL",{"date":32,"type":30},"2019-10-07",{"date":34,"type":19},"2026-12-31",{"name":36,"class":37},"Can-Am HIFU Inc.","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":46,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":48,"conditions":49,"keywords":50,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":57,"locationsCount":38},"100452314","aquablation-in-benign-prostatic-hyperplasia-in-canada-100452314","NCT05169892","Aquablation in Benign Prostatic Hyperplasia in Canada","Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH)\n* Male subjects of ≥ 18 years of age\n* Candidate for Aquablation therapy as per clinical decision of Investigator\n* Willing and able to accurately complete questionnaires\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.",{"count":47,"type":19},25,"To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.",[23],[25],"2021-12-09",{"date":53,"type":30},"2021-12-27",{"date":55,"type":30},"2019-10-09",{"date":34,"type":19},{"name":36,"class":37},""]